Category: C.R. Bard
Here's a look at some of the top legal news stories for medical device companies this week: Stryker settles OtisMed beef for $80m; Bard battles move to consolidate pelvic mesh cases; Palmaz Scientific sues law firms; No new trials for ex-ArthroCare CEO, CFO; Ex-Heart Tronics-Signalife exec draws 17-year sentence
Advanced Bio Prosthetic Surfaces
, Akin Gump Strauss Hauer & Feld
, ArthroCare Corp.
, Baker Botts
, Boston Scientific
, C.R. Bard
, Dept. of Justice (DOJ)
, Heart Tronics
, Palmaz Scientific
, Stryker Corp.
The federal judge overseeing thousands of product liability lawsuits filed against C.R. Bard over its pelvic mesh devices advises the medical device company to settle.
The federal judge overseeing thousands of lawsuits brought against C.R. Bard (NYSE:BCR) reportedly urged the company to settle this week during a hearing.
C.R. Bard fights a bid to consolidate 185 lawsuits filed against the company over its pelvic mesh products as part of a multi-district litigation.
C.R. Bard (NYSE:BCR) is fighting a bid by the plaintiffs in a raft of product liability lawsuits to have the 185 cases tried together.
The plaintiffs in 185 lawsuits filed against C.R. Bard over its Avaulta pelvic mesh as part of a multi-district litigation want their cases tried together.
Here's a look at some of the top legal news stories for medical device companies this week: J&J demands $7.2 billion from Boston Scientific as trial begins; Bard still on the hook for its share of $5m pelvic mesh verdict; Boston Scientific to pay $18.5m in pelvic mesh case; Justice Dept. recoups $6B in False Claims Act cases
Back-to-back losses in pelvic mesh lawsuits could drive up the cost – and urgency – of settling thousands of other such cases for Boston Scientific, legal experts say.
A California appeals court upholds a $5 million judgment against C.R. Bard and the surgeon involved in a product liability lawsuit filed over its Avaulta pelvic mesh.